Skip Nav Destination
Dicer is selectively important for the earliest stages of erythroid development
Pediatric-type nodal follicular lymphoma: an indolent clonal proliferation in children and adults with high proliferation index and no BCL2 rearrangement
Revised International Prognostic Scoring System for Myelodysplastic Syndromes
BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis
Safety and pharmacokinetics of a novel recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in hemophilia B patients
Outcome of high-risk acute myeloid leukemia after allogeneic hematopoietic cell transplantation: negative impact of abnl(17p) and −5/5q−
Issue Archive
September 20 2012
Table of Contents
Inside Blood
Blood Work
Editorial
Review Article
How I Treat
Clinical Trials and Observations
Hematopoiesis and Stem Cells
Dicer is selectively important for the earliest stages of erythroid development
Brief Report
Natalija Buza-Vidas,Valeriu B. Cismasiu,Susan Moore,Adam J. Mead,Petter S. Woll,Michael Lutteropp,Luca Melchiori,Sidinh Luc,Tiphaine Bouriez-Jones,Deborah Atkinson,Donal O'Carroll,Sten Eirik W. Jacobsen,Claus Nerlov
Immunobiology
Depletion of radio-resistant regulatory T cells enhances antitumor immunity during recovery from lymphopenia
Junko Baba,Satoshi Watanabe,Yu Saida,Tomohiro Tanaka,Takao Miyabayashi,Jun Koshio,Kosuke Ichikawa,Koichiro Nozaki,Toshiyuki Koya,Katsuya Deguchi,Chunrui Tan,Satoru Miura,Hiroshi Tanaka,Junta Tanaka,Hiroshi Kagamu,Hirohisa Yoshizawa,Ko Nakata,Ichiei Narita
Lymphoid Neoplasia
Pediatric-type nodal follicular lymphoma: an indolent clonal proliferation in children and adults with high proliferation index and no BCL2 rearrangement
Clinical Trials & Observations
Abner Louissaint, Jr,Adam M. Ackerman,Dora Dias-Santagata,Judith A. Ferry,Ephraim P. Hochberg,Mary S. Huang,A. John Iafrate,Daniel O. Lara,Geraldine S. Pinkus,Itziar Salaverria,Zakir Siddiquee,Reiner Siebert,Howard J. Weinstein,Lawrence R. Zukerberg,Nancy Lee Harris,Robert P. Hasserjian
T-cell independent, B-cell receptor-mediated induction of telomerase activity differs among IGHV mutation-based subgroups of chronic lymphocytic leukemia patients
Rajendra N. Damle,Sonal Temburni,Taraneh Banapour,Santanu Paul,Patricia K. A. Mongini,Steven L. Allen,Jonathan E. Kolitz,Kanti R. Rai,Nicholas Chiorazzi
Myeloid Neoplasia
Revised International Prognostic Scoring System for Myelodysplastic Syndromes
Clinical Trials & Observations
Peter L. Greenberg,Heinz Tuechler,Julie Schanz,Guillermo Sanz,Guillermo Garcia-Manero,Francesc Solé,John M. Bennett,David Bowen,Pierre Fenaux,Francois Dreyfus,Hagop Kantarjian,Andrea Kuendgen,Alessandro Levis,Luca Malcovati,Mario Cazzola,Jaroslav Cermak,Christa Fonatsch,Michelle M. Le Beau,Marilyn L. Slovak,Otto Krieger,Michael Luebbert,Jaroslaw Maciejewski,Silvia M. M. Magalhaes,Yasushi Miyazaki,Michael Pfeilstöcker,Mikkael Sekeres,Wolfgang R. Sperr,Reinhard Stauder,Sudhir Tauro,Peter Valent,Teresa Vallespi,Arjan A. van de Loosdrecht,Ulrich Germing,Detlef Haase
Genome-wide methylation profiling in decitabine-treated patients with acute myeloid leukemia
Pearlly Yan,David Frankhouser,Mark Murphy,Hok-Hei Tam,Benjamin Rodriguez,John Curfman,Michael Trimarchi,Susan Geyer,Yue-Zhong Wu,Susan P. Whitman,Klaus Metzeler,Alison Walker,Rebecca Klisovic,Samson Jacob,Michael R. Grever,John C. Byrd,Clara D. Bloomfield,Ramiro Garzon,William Blum,Michael A. Caligiuri,Ralf Bundschuh,Guido Marcucci
BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis
e-blood
Felix Sahm,David Capper,Matthias Preusser,Jochen Meyer,Albrecht Stenzinger,Felix Lasitschka,Anna-Sophie Berghoff,Antje Habel,Marion Schneider,Andreas Kulozik,Ioannis Anagnostopoulos,Leonhard Müllauer,Gunhild Mechtersheimer,Andreas von Deimling
Platelets and Thrombopoiesis
Red Cells, Iron, and Erythropoiesis
Thrombosis and Hemostasis
Safety and pharmacokinetics of a novel recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in hemophilia B patients
Clinical Trials & Observations
Elena Santagostino,Claude Negrier,Robert Klamroth,Andreas Tiede,Ingrid Pabinger-Fasching,Christine Voigt,Iris Jacobs,Massimo Morfini
Transplantation
Outcome of high-risk acute myeloid leukemia after allogeneic hematopoietic cell transplantation: negative impact of abnl(17p) and −5/5q−
Clinical Trials & Observations
Jan M. Middeke,Dietrich Beelen,Michael Stadler,Gudrun Göhring,Brigitte Schlegelberger,Herrad Baurmann,Gesine Bug,Frauke Bellos,Brigitte Mohr,Stefanie Buchholz,Rainer Schwerdtfeger,Hans Martin,Ute Hegenbart,Gerhard Ehninger,Martin Bornhäuser,Johannes Schetelig,on behalf of the Cooperative German Transplant Study Group
B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways
Jessica L. Allen,Matthew S. Fore,Jenna Wooten,Philip A. Roehrs,Nazmim S. Bhuiya,Todd Hoffert,Andrew Sharf,Allison M. Deal,Paul Armistead,James Coghill,Don A. Gabriel,Robert Irons,Amber Essenmacher,Thomas C. Shea,Kristy Richards,Corey Cutler,Jerome Ritz,Jonathan Serody,Albert S. Baldwin,Stefanie Sarantopoulos
-
Cover Image
Cover Image
![issue cover]()
This image provides a nomogram for determining the Revised International Prognostic Scoring System age-adjusted risk category for patients with myelodysplastic syndromes (MDS). Since age has a major impact on the survival of MDS patients, this patient-associated risk score adjustment has value additive to the clinically defined disease-associated features of the individual. See the article by Greenberg et al on page 2454.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement
Email alerts
Advertisement
